Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 30;15(4):149-155.
doi: 10.4103/jgid.jgid_138_23. eCollection 2023 Oct-Dec.

Epidemiological Study of Respiratory Virus Infections among Hospitalized Children Aged 14 Years and Younger during COVID-19 Pandemic in Wuhan, China, 2018-2022

Yingchan Hao  1 , Li Cheng  1 , Dan Lu  1
Affiliations

Epidemiological Study of Respiratory Virus Infections among Hospitalized Children Aged 14 Years and Younger during COVID-19 Pandemic in Wuhan, China, 2018-2022

Yingchan Hao et al. J Glob Infect Dis. .

Abstract

Introduction: The viral etiological characteristics and prevalence of hospitalized children with acute respiratory tract infection were preliminary studied in Wuhan City during the COVID-19 pandemic, to provide a reliable scientific basis for better understanding of the role of various pathogens in cases and for the prevention and clinical treatment of acute respiratory tract infection.

Methods: A total of 69,086 children with acute respiratory infections hospitalized and treated in our department from January 2018 to December 2022 were enrolled as our research subjects. Sociodemographic and clinical data as well as nasopharyngeal samples were collected from patients. Respiratory syncytial virus (RSV), adenovirus (ADV), infuenza virus A (FluA), infuenza virus B (FluB), and parainfluenza virus (PIV) were detected by direct immunofluorescence (DFA) to understand and analyze the epidemic characteristics of respiratory pathogens in children during the COVID-19 pandemic.

Results: The total detection rate of respiratory pathogens was 24.52% of the 69,086 hospitalized children. The frequency of respiratory viruses in those ADV, RSV, FluA, FluB, and PIV was 14.67%, 46.40%, 7.76%, 5.23%, and 25.95%. There were significant differences between the various pathogens (P < 0.001). There were the fewest pathogen-positive patients and positive detection rate in 2020 during the COVID-19 pandemic. There were significant differences in the pathogen detection rate among different years (P < 0.001). In addition, the results showed that the total detection rate of respiratory virus tested in different age groups was significantly different (P < 0.001). The positive detection rate was highest in the 1-3-year-old age group, which is prone to acute respiratory infections. We also found that different pathogens showed obvious seasonal fluctuation and epidemic. RSV reached its peak in winter. ADV is mainly prevalent in spring and summer. FluA has a high detection rate in winter. Winter and spring are the peak seasons for FluB infection, whereas PIV is detected in all seasons, with a higher incidence rate in the spring and summer.

Conclusion: The epidemiological distribution of pathogens of acute respiratory tract infection in hospitalized children in Wuhan from 2018 to 2022 varies with gender, age, and season. Nonpharmaceutical interventions (NPIs) were implemented as control measures worldwide and reduced the transmission of respiratory pathogens. NPIs are likely to be the primary driver of the dramatic reduction in respiratory virus infection activity in the early stages of the COVID-19 pandemic, to dissolving NPIs can lead to a recurrence of viral infection pathogens, especially in children.

Keywords: Acute respiratory tract infection; children; epidemiology; hospitalization; nonpharmaceutical interventions; respiratory viruses.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
The number and percentage of positive detections of each various respiratory viruses. ADV: Adenovirus, RSV: Respiratory syncytial virus, PIV: Parainfluenza virus, FluA: Infuenza virus A, FluB: Infuenza virus B
Figure 2
Figure 2
The number and percentage of positive pathogens at different years. (a) The number of ARI cases between 2018 and 2022, (b) The number of positive cases between 2018 and 2022, (c) The percentage of positive cases between 2018 and 2022. ARI: Acute respiratory infection
Figure 3
Figure 3
Distribution of respiratory pathogens in the different age groups between 2018 and 2022. (a) Adenovirus, (b) Respiratory syncytial virus, (c) FluA, (d) FluB, (e) Parainfluenza virus. ADV: Adenovirus, RSV: Respiratory syncytial virus, PIV: Parainfluenza virus, FluA: Infuenza virus A, FluB: Infuenza virus B
Figure 4
Figure 4
Distribution of respiratory pathogens in the different months between 2018 and 2022. (a) Adenovirus, (b) Respiratory syncytial virus, (c) FluA, (d) FluB, (e) Parainfluenza virus. ADV: Adenovirus, RSV: Respiratory syncytial virus, PIV: Parainfluenza virus, FluA: Infuenza virus A, FluB: Infuenza virus B
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Merera AM. Determinants of acute respiratory infection among under-five children in rural Ethiopia. BMC Infect Dis. 2021;21:1203. - PMC - PubMed
    1. Walker GJ, Stelzer-Braid S, Shorter C, Honeywill C, Wynn M, Willenborg C, et al. Viruses associated with acute respiratory infection in a community-based cohort of healthy New Zealand children. J Med Virol. 2022;94:454–60. - PMC - PubMed
    1. Dagne H, Andualem Z, Dagnew B, Taddese AA. Acute respiratory infection and its associated factors among children under-five years attending pediatrics ward at University of Gondar comprehensive specialized hospital, Northwest Ethiopia: Institution-based cross-sectional study. BMC Pediatr. 2020;20:93. - PMC - PubMed
    1. Niederman MS, Torres A. Respiratory infections. Eur Respir Rev. 2022;31:220150. - PMC - PubMed
    1. Perra N. Non-pharmaceutical interventions during the COVID-19 pandemic: A review. Phys Rep. 2021;913:1–52. - PMC - PubMed